Parenteral nutrition is a feasible option for adult and child patients without functional gastrointestinal tract or disorders requiring complete bowel rest that include certain stages of ulcerative colitis, intestinal obstruction, along with short bowel syndrome resulting from surgery. Severely ill people are often at an increased risk of malnutrition. Acute and chronic illness, trauma and inflammation induced stress-related catabolism, and drug-induced adverse effects may reduce appetite or increase nausea and vomiting especially in children. The prescribed levels of specific nutrients provided for the adult receiving parenteral nutrition should be based on a formal nutritional assessment recommended by healthcare professionals. Nutritional requirements should include disease specific needs based on patient type, that is adults, children and new born babies and factors to be considered include medical condition, nutritional status together with fluid restrictions and organ function
Infants and children are likely to suffer from biochemical essential fatty acid deficiency within a week or two, if administered with a fat-free diet. Premature infants have a number of unique characteristics that affect the application and safety of parenteral nutrition. The consequences of malnutrition are extreme, critical and diverse, and can severely affect all organs in the body. Failure to provide adequate nutrition leads to ill health, which can lead to immune dysfunction, tangled physiological function and delayed wound healing especially in adult patients
Amino acids composition segment in the parenteral nutrition market valued at around USD 1.75 billion in 2018 owing to increase in cases of hepatic insufficiency and renal insufficiency globally. Deficiency of protein diet is common in critically ill patients, that leads to occurrence of protein-energy malnutrition diseases and fat loss. In such cases patients are treated with amino acid rich parenteral products. Thus, spurring the growth of parenteral nutrition products
With rising acceptance rate in developing nations, the vitamin-based parenteral nutrition is predicted to show a reasonable growth. With the increasing prevalence of appetite conditions in millennials such as anorexia and inadequate digestion will foster the demand for vitamin based parenteral nutrition products
North America market ruled the general market in 2018, inferable from the nearness of high research consumption by government offices and private substances in the human services segment, mechanically propelled medicinal gadgets, and coordinated efforts among administrative experts, restorative gadget industry, and colleges. In addition, the rising event of a few perpetual ailments, the presence of cutting edge social insurance offices, just as good repayment strategies have prompted an expansion in the emergency clinic confirmation that is foreseen to support the use rates in this district
The parenteral nourishment market in the Asia Pacific is anticipated to grow at an outstanding CAGR amid the figure time frame. The high pervasiveness of unending kidney issue in exceptionally populated nations, for example, China and India, quick improvement in social insurance framework, increment in access to medicinal services offices and ascend in per capita human services use in the area are probably going to fuel the market in the Asia Pacific amid the figure time frame. The extensive base of pharmaceutical organizations in nations, for example, India, Japan, and China likewise drive the market in the locale. Rising economies and extension of pharmaceutical markets in nations, for example, China, India, Indonesia, Singapore, Taiwan, and Thailand are relied upon to move the market in the Asia Pacific. Rising instances of preterm birth, which prompts unhealthiness, is a key reason fuelling the utilization of parenteral sustenance in the Asia Pacific
Asia Pacific is the fastest growing region in global the market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market. Moreover, favourable government policies and increasing healthcare expenditures fuels the market growth within the region
On the other hand, the Middle East & Africa holds the least share in the global osteoarthritis market due to presence of poor economy, especially, in African region. Majority of the market of this region is held by the Middle East due to the well-developed healthcare sector and huge healthcare expenditure by the presence of economies like Kuwait, Saudi Arabia, Dubai and Qatar.
Key Industry Players
The leading companies in the parenteral nutrition market includes B. Braun Melsungen AG, Otsuka Pharmaceutical Factory Inc., Baxter International Inc., Allergan plc. (Actavis plc.), Grifols S.A.,Pfizer Inc., Sichuan Kelun Pharmaceutical Co. Ltd., Claris Lifesciences Limited, Fresenius SE & Co. KGaA, and others.
Otsuka Pharmaceutical Factory Inc. delivers various parenteral nutrition products including Celemin, Celepid MCT-LCT, TNA/TNA-Peri, Celemix, and Elemun to the leading hospitals and clinics.